
Journal Menu
► ▼ Journal Menu-
- Current Oncology Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal Browser-
arrow_forward_ios
Forthcoming issue
arrow_forward_ios Current issue - Volumes not published by MDPI
Need Help?
Announcements
11 September 2025
Meet Us at the 38th Annual Congress of the European Association of Nuclear Medicine, 4–8 October 2025, Barcelona, Spain

Conference: 38th Annual Congress of the European Association of Nuclear Medicine
Date: 4–8 October 2025
Location: Barcelona, Spain
We are pleased to announce that MDPI will participate in the 38th Annual Congress of the European Association of Nuclear Medicine (EANM25), to be held in Barcelona, Spain, from 4 to 8 October 2025.
One of the highlights of this year’s congress will be the continued focus on novel advances in theranostics. This rapidly evolving field continues to revolutionize our approach to diagnosis and treatment, offering unprecedented precision and personalized care for our patients. We have an exciting program lined up, featuring leading experts who will share their insights and latest research findings.
MDPI is excited to participate in this prestigious event! Representing the journal Diagnostics (ISSN: 2075-4418), Ms. Florina Maria Muresan and Ms. Lassie Shu will be present at the MDPI exhibition stand, where they will warmly welcome all scholars to stop by and engage in insightful discussions. This event presents a unique opportunity for participants to interact with leading experts in the field and explore potential collaborations. Do not miss the chance to visit our stand and exchange ideas with the MDPI editors and other delegates!
9 September 2025
Current Oncology | Highly Cited Papers and Hot Topic Special Issues on Psychosocial Oncology
Psycho-oncology deals with psychological reactions to the experience of cancer, the behavioral component of coping with cancer, as well as health behavior change, including preventative medicine, and social factors that are associated with the diagnosis and treatment of cancer. We welcome you to read the following highly cited papers published in the Current Oncology (ISSN: 1718-7729) and hope that these articles can bring new ideas for psycho-oncology research. In addition, some Special Issues on this topic are currently open for submission.
1. “Psychosocial Interventions for the Treatment of Cancer-Related Fatigue: An Umbrella Review”
by Nieves Cedenilla Ramón, Jose Ignacio Calvo Arenillas, Sandra Aranda Valero, Alba Sánchez Guzmán and Pedro Moruno Miralles
Curr. Oncol. 2023, 30(3), 2954-2977; https://doi.org/10.3390/curroncol30030226
Available online: https://www.mdpi.com/1718-7729/30/3/226
2. “The Stigma Surrounding Opioid Use as a Barrier to Cancer-Pain Management: An Overview of Experiences with Fear, Shame, and Poorly Controlled Pain in the Context of Advanced Cancer”
by Hannah Harsanyi, Colleen Cuthbert and Fiona Schulte
Curr. Oncol. 2023, 30(6), 5835-5848; https://doi.org/10.3390/curroncol30060437
Available online: https://www.mdpi.com/1718-7729/30/6/437
3. “Is It Possible to Notice the Unmet Non-Medical Needs among Cancer Patients? Application of the Needs Evaluation Questionnaire in Men with Lung Cancer”
by Karolina Osowiecka, Marcin Kurowicki, Jarosław Kołb-Sielecki, Anna Gwara, Marek Szwiec, Sergiusz Nawrocki and Monika Rucinska
Curr. Oncol. 2023, 30(3), 3484-3493; https://doi.org/10.3390/curroncol30030264
Available online: https://www.mdpi.com/1718-7729/30/3/264
4. “Quality of Life in Cancer Patients: The Modern Psycho-Oncologic Approach for Romania—A Review”
by Monica Licu, Claudiu Gabriel Ionescu and Sorin Paun
Curr. Oncol. 2023, 30(7), 6964-6975; https://doi.org/10.3390/curroncol30070504
Available online: https://www.mdpi.com/1718-7729/30/7/504
5. “Psychosocial Wellbeing among Patients with Breast Cancer during COVID-19”
by Martine C. Maculaitis, Xianchen Liu, Alexandra Berk, Angelina Massa, Marisa C. Weiss, Samantha K. Kurosky, Benjamin Li and Lynn McRoy
Curr. Oncol. 2023, 30(4), 3886-3900; https://doi.org/10.3390/curroncol30040294
Available online: https://www.mdpi.com/1718-7729/30/4/294
6. “Are Canadian Women Prepared for the Transition to Primary HPV Testing in Cervical Screening? A National Survey of Knowledge, Attitudes, and Beliefs”
by Ben Haward, Ovidiu Tatar, Patricia Zhu, Gabrielle Griffin-Mathieu, Emily McBride, Jo Waller, Julia Brotherton, Aisha Lofters, Marie-Hélène Mayrand, Samara Perez et al.
Curr. Oncol. 2023, 30(7), 7055-7072; https://doi.org/10.3390/curroncol30070512
Available online: https://www.mdpi.com/1718-7729/30/7/512
7. “Beauty Therapy to Support Psychosocial Recovery from Oncological Care: A Qualitative Research on the Lived Experience of Women with Breast Cancer Treated with Chemotherapy”
by Denise Vagnini, Massimo Maria Grassi, Francesco Valenti, Emilio Bombardieri and Emanuela Saita
Curr. Oncol. 2024, 31(5), 2527-2541; https://doi.org/10.3390/curroncol31050189
Available online: https://www.mdpi.com/1718-7729/31/5/189
8. “Positive Psychological Well-Being in Early Palliative Care: A Narrative Review of the Roles of Hope, Gratitude, and Death Acceptance”
by Elena Bandieri, Eleonora Borelli, Sarah Bigi, Claudia Mucciarini, Fabio Gilioli, Umberto Ferrari, Sonia Eliardo, Mario Luppi and Leonardo Potenza
Curr. Oncol. 2024, 31(2), 672-684; https://doi.org/10.3390/curroncol31020049
Available online: https://www.mdpi.com/1718-7729/31/2/49
9. “Applying Implementation Science to Identify Primary Care Providers’ Enablers and Barriers to Using Survivorship Care Plans”
by Brittany Mutsaers, Tori Langmuir, Carrie MacDonald-Liska, Justin Presseau, Gail Larocque, Cheryl Harris, Marie-Hélène Chomienne, Lauriane Giguère, Paola Michelle Garcia Mairena, Dina Babiker et al.
Curr. Oncol. 2024, 31(6), 3278-3290; https://doi.org/10.3390/curroncol31060249
Available online: https://www.mdpi.com/1718-7729/31/6/249
10. “Two-Step Screening for Depression and Anxiety in Patients with Cancer: A Retrospective Validation Study Using Real-World Data”
by Bryan Gascon, Joel Elman, Alyssa Macedo, Yvonne Leung, Gary Rodin and Madeline Li
Curr. Oncol. 2024, 31(11), 6488-6501; https://doi.org/10.3390/curroncol31110481
Available online: https://www.mdpi.com/1718-7729/31/11/481
Special Issues:
|
|
“Psychological Interventions for Cancer Survivors” Guest Editor: Dr. Christian Schulz-Quach Submission deadline: 31 December 2025 |
“Pathways to Recovery and Resilience in Breast Cancer Survivorship” Guest Editor: Prof. Dr. Nazanin Derakhshan Submission deadline: 31 December 2025 |
|
|
“Routine Screening for Distress, Depression and Anxiety in Oncology: Where Are We Now?” Guest Editors: Dr. Daniel C. McFarland and Dr. Lee A. Kehoe Submission deadline: 31 January 2026 |
“Health Disparities and Outcomes in Cancer Survivors” Guest Editor: Dr. Claire Jungyoun Han Submission deadline: 30 April 2026 |
9 September 2025
Current Oncology | Invitation to Explore the Editor’s Choice Articles
Editor’s Choice Articles are selected based on suggestions from the Academic Editors of Current Oncology (ISSN: 1718-7729). The editors select a small number of published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are therefore invited to read the Editor’s Choice Articles, a curated list of high-quality articles published in Current Oncology. The full list of Editor’s Choice Articles can be viewed via the following link: https://www.mdpi.com/journal/curroncol/editors_choice.
1. “Pediatric Brain Tumours: Lessons from the Immune Microenvironment”
by Betty Yao, Alberto Delaidelli, Hannes Vogel and Poul H. Sorensen
Curr. Oncol. 2023, 30(5), 5024-5046; https://doi.org/10.3390/curroncol30050379
2. “Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma”
by Luisa M. Cardenas, Jasna E. Deluce, Shahrukh Khan, Omar Gulam, Saman Maleki Vareki, Ricardo Fernandes and Aly-Khan A. Lalani
Curr. Oncol. 2022, 29(8), 5426-5441; https://doi.org/10.3390/curroncol29080429
3. “Invasive Fungal Disease in Patients with Chronic Lymphocytic Leukemia in Japan: A Retrospective Database Study”
by Takeo Yasu, Kotono Sakurai and Manabu Akazawa
Curr. Oncol. 2022, 29(5), 3242-3251; https://doi.org/10.3390/curroncol29050264
4. “Cancer-Associated Fibroblasts and Extracellular Matrix: Therapeutical Strategies for Modulating the Cholangiocarcinoma Microenvironment”
by Mirko Minini and Laura Fouassier
Curr. Oncol. 2023, 30(4), 4185-4196; https://doi.org/10.3390/curroncol30040319
5. “Neurologic Complications of Cancer Immunotherapy”
by Aseel N. Alsalem, Leslie A. Scarffe, Hannah R. Briemberg, Ashley E. Aaroe and Rebecca A. Harrison
Curr. Oncol. 2023, 30(6), 5876-5897; https://doi.org/10.3390/curroncol30060440
6. “Evolution of the Surgical Management of Lung Cancer Invading the Spine: A Single Center Experience”
by Gabrielle Drevet, Théo Broussolle, Yanis Belaroussi, Lucie Duponchelle, Jean Michel Maury, Renaud Grima, Gualter Vaz, Clément Silvestre and François Tronc
Curr. Oncol. 2022, 29(5), 3061-3071; https://doi.org/10.3390/curroncol29050248
7. “X or Y Cancer: An Extensive Analysis of Sex Differences in Lung Adenocarcinoma”
by Raneem Yaseen Hammouz, Magdalena Orzechowska, Dorota Anusewicz and Andrzej K. Bednarek
Curr. Oncol. 2023, 30(2), 1395-1415; https://doi.org/10.3390/curroncol30020107
8. “Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review”
by Jessie Luo, Nizar J. Bahlis, Denise Chan, Peter Duggan, Victor H. Jimenez-Zepeda, Holly Lee, Sylvia McCulloch, Paola Neri and Jason Tay
Curr. Oncol. 2024, 31(12), 7445-7458; https://doi.org/10.3390/curroncol31120550
3 September 2025
Join Us at the MDPI at the University of Toronto Career Fair, 23 September 2025, Toronto, ON, Canada

Date: 23 September 2025
Time: 11:00 a.m.–4:30 p.m
Location: The Chelsea Hotel, 33 Gerrard Street West, Toronto
MDPI is thrilled to announce our participation in the University of Toronto’s largest career fair, taking place at the St. George Downtown Campus. This exciting event brings together thousands of students, graduates, and professionals looking to connect with top employers and explore career opportunities.
We invite all attendees to visit the MDPI booth to discover how you can be part of one of the world’s leading open access academic publishers. Whether you are passionate about scientific research, editorial work, marketing, or supporting global innovation in publishing, we want to meet YOU!
What to expect at our booth:
- Learn more about MDPI’s mission and global impact;
- Explore exciting career opportunities in publishing, editorial, communications, and more;
- Network with our team and ask questions about working at MDPI.
Whether you’re just starting your career or looking to take the next step, don’t miss this opportunity to connect with MDPI. Bring your resume, your curiosity, and your questions—we look forward to seeing you there!
For additional information on the Career Fair and Open MDPI positions, please visit the following links:
1 September 2025
MDPI INSIGHTS: The CEO’s Letter #26 – CUJS, Head of Ethics, Open Peer Review, AIS 2025, Reviewer Recognition

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Society of China University Journals (CUJS) visit to MDPI Basel
In August, we had the pleasure of welcoming a delegation from the Society of China University Journals (CUJS) to our Basel headquarters. The visit was part of CUJS’s broader European tour, which included meetings with several major publishing organizations.
Purpose of the visit
The delegation’s stop in Basel involved an introductory meeting and knowledge-sharing with a view to identifying potential collaboration opportunities with MDPI. The CUJS team shared an overview of the Chinese scientific publishing landscape, including recent policy developments, and gave us insights into the journals and services they operate across China’s academic institutions.
MDPI presentations
We used the opportunity to introduce CUJS to MDPI’s mission, structure, and recent achievements. I presented on the latest developments at MDPI and our role in supporting global open access, addressing many follow-up questions from the delegation. Warm thanks are due to the following colleagues for their contributions to the session:
- Liliane Auwerter (Conference Organizer, Scientific Officer and Sustainability Specialist) shared an overview of our editorial process, including the quality indicators we use to track peer-review performance.
- Renato Merki (Publication Ethics Assistant) presented on behalf of our Research Integrity and Ethics team, emphasizing our commitment to responsible publishing.
- Silvano Bonfatti (Product Manager) introduced the JAMS platform, highlighting how it supports efficient journal management for editors and publishers alike.
- Aimar Xiong (Publisher, Section Managing Editor) and Giuliano Braccini (Office Manager) facilitated the meeting, offering clarity in response to specific questions, building the relationship during and beyond the meeting itself.
“Building relationships with organizations such as CUJS allows us to increase our visibility and reputation”
Why is this important?
China is one of the world’s largest producers of scientific research, with its universities and research institutes playing a key role in global scholarly publishing. Building strong relationships with influential organizations such as CUJS allows us to increase our visibility and reputation vis-à-vis the Chinese academic community, share best practices, learn from differing publishing models, and explore collaborations that have the potential to enhance the quality, reach, and diversity of our journals.
Looking ahead
It was a productive and friendly exchange that reflected our shared commitment to advancing scholarly communication and improving journal publishing practices. We value these visits, which allow us to create collaborations with stakeholders in the global academic community.
Our Basel office is a hub for hosting international delegations, partners, and collaborators. We look forward to creating more global connections that support our mission.
Impactful Research
Appointment of Dr. Tim Tait-Jamieson as Head of Publication Ethics
As part of our ongoing commitment to research integrity and publishing excellence, I am delighted to announce that we have appointed Dr. Tim Tait-Jamieson as Head of Publication Ethics.
In this role, Tim will lead the development of our ethics strategy and oversee the continued growth of the Publication Ethics Department, which is based across our offices in Basel, Manchester, Belgrade/Novi Sad, and Cluj. Guided by the principles of effective prevention and efficient resolution, the department plays an essential role in ensuring the highest standards of integrity throughout our editorial processes.
Department focus
Working closely with internal teams and external partners, the Publication Ethics Department focuses on refining our policies, aligning our operations with international best practices, and addressing complex cases with fairness and transparency. This work is critical in supporting our editors, reviewers, and authors, reinforcing MDPI’s contribution to the global dialogue on research integrity.
“Research integrity is something to which we all contribute through our daily work at MDPI”
About Tim
Tim joined MDPI in 2021 and has held several roles within the Publication Ethics Department, most recently serving as Research Integrity Lead. Based in our Basel office, he brings a strong academic background, with a Ph.D. in Geography from the University of Fribourg, Switzerland, and a proven track record of leadership in research integrity.
Research integrity is something to which we all contribute through our daily work at MDPI. I look forward to Tim’s leadership as we continue investing in the people, processes, and partnerships that uphold the trust and credibility of scholarly publishing.
Read more:
Inside MDPI
How and why MDPI offers Open Peer Review
At MDPI, we are committed to advancing openness and transparency in scholarly publishing. One area where we’ve taken a leadership role is peer review. Since 2014, MDPI has offered authors the option of open peer review, giving them the opportunity to publish reviewer comments alongside their papers. Each year, more authors are choosing this path, helping to build trust in the editorial process and provide valuable context for the research we publish.
Jack McKenna (Senior Content Specialist, MDPI) recently wrote an informative piece looking at the impact and importance of open peer review at MDPI. He highlights how this approach not only benefits readers but also gives well-deserved recognition to our reviewers, who generously dedicate their time and expertise to the academic community.
I encourage you to read this blogpost to see how MDPI is helping set standards for transparency in scholarly publishing.
Coming Together for Science
Recap of MDPI’s AIS 2025 Conference in Kuala Lumpur
Entering the month of August, we held The 2nd International Conference on AI Sensors and Transducers (AIS 2025) in Kuala Lumpur, Malaysia.
“AIS is quickly becoming a premier event in the field”
The second edition of AIS brought together 335 attendees from across Asia and beyond, including participants from China, Japan, Korea, and Southeast Asia. The event, chaired by Prof. Dr. Toshihiro Itoh (University of Tokyo), Prof. Dr. Sang-Woo Kim (Yonsei University), and Prof. Dr. Chengkuo Lee (National University of Singapore), continues to grow in reputation and has become an important platform for researchers and students to present their work, exchange ideas, and build international collaborations.
AIS is quickly becoming a premier event in the field, with participants highlighting its quality of service, its expanding academic network, and the value it delivers in the context of tightening research budgets in the region.
It was also excellent to see our new MDPI journal AI Sensors, which originated from a conference topic, host a successful launch party at the event.
Highlights from participant feedback:
- Southeast University (China) sent a student delegation and considers AIS a regular fixture for Ph.D. students in need of international conference experience.
- CAS Aerospace Information Research Institute sent a 10-member delegation and plans to further promote AIS internally.
- Japanese researchers regard AIS as a must-attend event, placing it on a par with IEEE conferences and citing the benefits of networking and exchange.
- Korean academics praised the organization and noted improved perceptions of MDPI among their institutions, viewing AIS as a strategic opportunity to deepen engagement in the region.
Award winners
We recognized the recipients of the Best Presentation, Best Scientist, Best Poster, and Best Student Paper awards, whose contributions set a standard for academic excellence. The full award announcement is available here.
Looking ahead
The 3rd International Conference on AI Sensors and Transducers will be held from 5 to10 August 2026 in Jeju, Korea. The General Chairs will be Prof. Inkyu Park (Korea Advanced Institute of Science and Technology), Prof. Zhou Li (Tsinghua University), Prof. Xinge Yu (City University of Hong Kong), and Prof. Chengkuo Lee (National University of Singapore). We look forward to bringing together innovators, researchers and experts who are shaping the future at the intersection of sensors, sensing technology, transducers and artificial intelligence.
Thank you
Our conference team managed this event with great agility and professionalism and are already planning improvements to make the conference even more accessible. Special thanks to the National University of Singapore for their support, and to our entire conference team and collaborators for their dedication.
AIS is gaining momentum, and we look forward to supporting its role as a bridge between MDPI and the global academic community.
“Our conference team managed this event with great agility and professionalism”
Closing Thoughts
Recognizing our outstanding reviewers
As we close this edition of the newsletter, I would like to spotlight MDPI’s 2024 Outstanding Reviewer Awards, which showcase a group of winners whose contributions often go unseen but are essential to the integrity of scholarly publishing: our reviewers.
In 2024, more than 215,000 reviewers dedicated their time and expertise to MDPI journals. From this community, we are proud to recognize 356 recipients of the Outstanding Reviewer Awards, who went above and beyond by providing timely, thorough and constructive feedback.
These awards are not only a token of our appreciation but also a reflection of the values we stand for: rigor, fairness and collaboration in advancing science.
To explore the full list of awardees across disciplines, from life sciences to the humanities, please visit the following pages:
- Biology and Life Sciences
- Business and Economics
- Chemistry and Materials Science
- Computer Science and Mathematics
- Engineering
- Environmental and Earth Sciences
- Medicine and Pharmacology
- Physical Sciences
- Public Health and Healthcare
- Social Sciences, Arts and Humanities
About MDPI Awards
To recognize the academic community, MDPI journals regularly offer various awards to researchers in specific fields. Serving as a source of recognition and inspiration, these awards help increase the influence of scholars who have been credited with outstanding achievements and are making a significant contribution to the advancement of their respective fields.
To explore more opening Outstanding Reviewer Awards, please click here.
To all our reviewers: thank you for being the foundation of trust that makes open access publishing possible!
Chief Executive Officer
MDPI AG
19 August 2025
Meet Us at the 84th Annual Meeting of the Japanese Cancer Association, 25–27 September 2025, Kanazawa, Japan

MDPI will be attending the 84th Annual Meeting of the Japanese Cancer Association from 25 to 27 September 2025 in Kanazawa City, Ishikawa Prefecture, Japan. We welcome researchers from diverse backgrounds to visit our booth and share their latest ideas with us.
The Annual Meeting is a major event regularly organized by the Japanese Cancer Association to disseminate the latest achievements in cancer research. The 84th Annual Meeting, held under the theme “Believe in the power of cancer research”, emphasizes innovative basic research to deepen our understanding of cancer biology and drive the development of new therapeutic strategies. A total of 20 symposia will be held, each focusing on a specific, cutting-edge research topic, and special lectures will be presented by world-leading cancer researchers. The conference will provide participants with the opportunity to engage with the forefront of international research.
The following MDPI journals will be represented:
- Cancers;
- Journal of Clinical Medicine;
- Diseases;
- Current Oncology;
- Clinics and Practice;
- Medical Sciences;
- Onco;
- Radiation.
We welcome you to visit the MDPI booth (#J-2) at the Hotel Nikko Kanazawa. Our representatives are excited to meet you in person and address any questions you may have. For further details about the conference, please visit the following website: https://www.c-linkage.co.jp/jca2025/en/.
31 July 2025
MDPI INSIGHTS: The CEO's Letter #25 - 8,000 Staff Worldwide, Korea Visit, 100,000 Preprints, Malaysia Roundtable, Canada Consortium Deal

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Talent Drives Our Progress
For the first time in MDPI’s history, we now have over 8,000 colleagues across the company. I would like to take a moment to celebrate this milestone and acknowledge the driving force behind our growth and success: our people.
As the world’s leading fully open access publisher, MDPI has grown thanks to the dedication, talent, and teamwork of colleagues across the company. Already halfway through 2025, we’ve welcomed nearly 2,000 new colleagues.
“Our achievements are also about the people behind them”
We now manage over 475 journals, with 298 receiving an Impact Factor, and hundreds more indexed in major databases, including 343 in Scopus, and 92 by PubMed. As the reach and impact of our journals continues to grow, so does the need for dedicated and qualified teams to support that growth. Thus, attracting and retaining exceptional talent remains a cornerstone of our success.
Our achievements are not just about the results of journal expansion, however: they’re about the people behind them. From our hardworking editors to our meticulous English editing and production teams – from our journal relationship specialists, public relations, marketing and communications professionals to our conference teams and the project teams behind Preprints, Scilit, SciProfiles, JAMS and more. Our success reflects the work of thousands of people showing up each day, taking pride in their work, and committed to excellence and service.
What we’re doing to support talent:
- Investing in onboarding and training to help new colleagues feel welcomed and empowered to thrive.
- Creating clearer career paths across all functions, from editorial to communications and beyond.
- Launching mentorship programs and internal knowledge-sharing sessions to promote growth and collaboration.
- Evolving our recognition and rewards programs to better celebrate your contributions.
- Expanding our training systems and platforms.
MDPI’s in-house training department offers over 215 training courses, covering topics from editorial development to cross-cultural collaboration. In 2024 alone, we had 44 full-time trainers and 196 part-time training assistants supporting the learning and development needs of colleagues worldwide. These efforts ensure our teams are equipped with the skills and confidence to grow professionally and contribute meaningfully.
Over two-thirds of our workforce is editorial, and of our more than 5,400 editors, 87% hold a Master’s degree and 6% a PhD. Their collective contributions are central to delivering a high-quality publishing experience and supporting global academic communication.
As we celebrate this milestone, we also aim to continue on a path of steady and sustainable growth, one that balances journal expansion with investment in people, outreach, processes, and innovation. Together, we are shaping the future of open access and academic publishing. Thank you for your hard work, your ideas, and your commitment to serving the global research community.
Let’s continue working together to create a culture where great talent grows and every colleague feels valued.
Impactful Research
Visiting South Korea: Building Connections and Supporting the MDPI Seoul Office
In July, I had the opportunity to visit our team in Seoul and engage directly with academic communities in South Korea. The visit focused on deepening MDPI’s relationships with local universities, institutions, and partners, and supporting the great work of our colleagues at the MDPI Seoul office.
Korea Association of Private University Libraries (KAPUL) Conference
A highlight of the visit was our participation in the Korea Association of Private University Libraries (KAPUL) Conference, where we presented to over 100 academic librarians. I delivered a keynote speech titled “The Evolving Publishing Landscape: Open Access and Beyond,” while my colleague Dr. Jisuk Kang (Public Affairs Specialist) shared insights in her presentation, “Inside MDPI: Editorial Practices & Research Integrity.”
Our participation received media coverage, including:
NEWS1: “Publishing Open Access Papers' MDPI...Supporting the Expansion of Korean Research Influence”
UNN (University News Network): “MDPI Announces ‘Seoul Declaration’... “Presenting Standards for Authenticity and Transparency in Korea”
Beyond Post: MDPI CEO Visits Korea to 'Support for the Development of Domestic Knowledge Ecosystem'
Facts & Figures: South Korea
- South Korea is MDPI’s sixth-largest publishing country by article volume (over 90,000 MDPI papers published to date).
- In 2024, Korea ranked 16th globally by total publications, and 6th (among these top 20 countries) by citation impact.
- 52% of Korean publications in 2024 were OA – and 73% of those were Gold OA.
- MDPI published about 20% of all OA papers from Korea in 2024.
- Over 2,000 active Editorial Board Members from South Korea contribute to MDPI journals, with 11 Section Editors-in-Chief.
- We currently have 11 Institutional Open Access Program agreements and two society partnerships in Korea:
- Korean Society of Pharmaceutical Sciences and Technology (with MDPI journal Pharmaceutics)
- Korean Tribology Society (with MDPI journal Coatings)
MDPI Seoul Office and the First Korea Salon
Our Seoul office serves as a regional hub for marketing, communications, and community engagement. It continues to grow in size and influence, prioritizing supporting scholar visits, conference sponsorships, and outreach events such as the recent MDPI Korea Salon.
The inaugural Salon, themed “Exploring Research Trends in Medical Publishing, Ethics, and AI,” brought together over 20 scholars and Editorial Board members serving MDPI journals.
Thank you to our guest speakers including Professors Young-Joon Surh of Seoul National University, Kwang-Sig Lee of Korea University, and Jin-Won Noh of Yonsei University who presented on the landscape of medicine in South Korea and across the globe. The Salon also included presentations from MDPI colleagues on Open Access, ethics, and how the IOAP can support researchers in this field.
“Our Seoul office continues to grow in size and influence”
Looking Ahead
MDPI is already the leading OA publisher in South Korea, yet challenges and misconceptions around OA and APCs remain. Visits like this one, along with the ongoing efforts of our Seoul office, are important to building understanding, trust, and long-term relationships with the local academic community.
A big thank-you to our colleagues in Seoul for their warm hospitality, professionalism, and energy! Our new office is well situated, staffed, and ready to grow. This visit marked an important step forward in our continued mission to support global research communities and advance Open Science.
Inside MDPI
Preprints.org Reaches 100,000 Preprints: A Major Milestone for MDPI and Open Science
In case you missed it, Preprints.org recently surpassed 100,000 preprints posted. This is a major milestone for our platform and one worth celebrating.
Preprints are a key pillar of the Open Science movement, which promotes transparency, equity, and faster knowledge-sharing through initiatives such as Open Access, Open Data, Open Source, and Open Peer Review. The benefits of Open Science extend beyond researchers, as they support funders, educators, policymakers, and the public in advancing discovery and innovation.
What is behind the 100,000 preprints milestone?
Since its launch in 2016, Preprints.org has grown into one of the world’s leading preprint platforms, now ranked fifth globally by publication volume.
More than 350,000 researchers have contributed, helping shape this dynamic and collaborative space for sharing early-stage research across all disciplines.
Read the full announcement here:
https://www.mdpi.com/about/announcements/12202
“Preprints.org has grown into one of the world’s leading preprint platforms”
Some quick facts worth noting:
- About 56% of the preprints on Preprints.org are later published in peer-reviewed journals.
- The platform is now indexed in Web of Science (Preprint Citation Index), Europe PMC, and Crossref, helping improve visibility and trust in the preprints shared.
- Recent upgrades – including a revamped website, new features such as search subscriptions, curated reading lists, and community feedback tools (PREreview) – show our commitment to developing Preprints.org in line with researchers’ needs.
This growth and progress would not be possible without the dedication of the Preprints.org team, our Advisory Board members, screeners, and colleagues across MDPI who support the platform’s development. This milestone is a reminder of our shared mission: to accelerate scientific communication and build a more open, transparent, and inclusive research ecosystem.
I’m excited to see what’s ahead as we approach Preprints.org’s 10-year anniversary in 2026!
Coming Together for Science
Malaysia Media Roundtable: Educating on Open Access and MDPI’s Presence in Southeast Asia
At the end of June, I had the opportunity to participate in a strategic media roundtable in Kuala Lumpur, focused on raising awareness about the importance of Open Access (OA) and on MDPI’s growing presence in Southeast Asia.
We welcomed five Malaysian media outlets for an engaging private session that included presentations and open discussion.
I gave an overview of the benefits of Open Access, MDPI’s global developments, and our collaborations in Malaysia.
My colleague Yu Nwe Soe (Public Relations Specialist), presented on our editorial process, helping to clarify how MDPI supports authors and maintains research quality.
We were also joined by two local Editorial Board Members (EBMs) who offered first-hand insights into their experiences working with MDPI and how OA has shaped their publishing choices.
The discussion covered a range of questions from the press, from OA publishing models to editorial standards, and highlighted MDPI’s unique contribution to accelerating scientific communication in the region.
As the leading fully OA publisher, we see it as our responsibility to continue educating research communities and the broader public on the impact of OA, especially in emerging and high-growth academic markets.
Spotlight on Malaysia
Malaysia continues to rise as a regional research hub, with five universities ranked in the global top 200 and 11 subjects in the global top 50. In 2024, Malaysia ranked 2nd in Southeast Asia in total publication output, 10th in Asia, and 25th globally.
MDPI’s presence in Malaysia:
- Over 21,000 research articles published to date from Malaysian institutions
- More than 1,100 articles published in 2024 alone
- In the period 2020–2024, 54% of Malaysia’s total publications were OA
- 36 EBMs from Malaysia, across 27 MDPI journals
- Around 100 conferences sponsored in Malaysia in the past five years
- MDPI is hosting the 2nd International Conference on AI Sensors and Transducers in Kuala Lumpur (29 July- 3 August 2025)
Media Coverage & Editorial Voices
Following the roundtable, we saw positive coverage across several local outlets, with articles highlighting MDPI’s role in empowering Malaysian researchers. Notable pieces included:
- Open-Access Empowers Malaysia’s Research Future
- Empowering Malaysian Researchers to Meet the Nation’s Innovation Ambitions
- MDPI and empowering Malaysian researchers
Our local EBMs also shared their perspectives:
Prof. Denny Ng Kok Sum (Sunway University, EBM of MDPI journal Processes) and Prof. Lee (EBM of MDPI journal Bacteria) share their experiences with MDPI and the role Open Access plays in their publication decisions.
“We see it as our responsibility to continue educating research communities on the impact of OA”
“I didn’t want my work stuck behind a paywall.”
— Prof. Denny Ng Kok Sum, Sunway University, Processes Editorial Board Member
“Open Access opens doors for collaboration and visibility, especially in fast-developing regions like ours.”
— Prof. Lee, Bacteria Editorial Board Member
This roundtable marked another step in building trust, understanding, and collaboration in Southeast Asia. A big thank-you to the MDPI Malaysia team and all those who contributed to the event’s success.
Closing Thoughts
MDPI Signs First North American Agreement with Canadian Consortium
We are proud to announce a major milestone for MDPI Canada and an important step forward for OA in North America.
In July, our Toronto office finalized MDPI’s first North American consortium agreement with the Federal Science Libraries Network (FSLN). This is a significant achievement that strengthens our expansion in Canada and reinforces our global commitment to supporting Open Science.
This two-year agreement gives Canadian federal agencies access to MDPI’s IOAP, including discounted article processing charges for affiliated researchers across our portfolio of over 475 OA journals. It lowers barriers for Canadian scientists to share their work more openly and reach a global audience.
Ryan Siu, Institutional Partnerships Manager at MDPI.
“The Open Science landscape in Canada is rapidly evolving, with the Tri-Agency Open Access Policy set for renewal by the end of 2025. This reflects ongoing efforts to foster greater scientific transparency and accessibility at a national policy level,” says Ryan Siu, Institutional Partnerships Manager at MDPI.
“Our new agreement with FSLN represents our shared commitment to further these efforts and foster wider readership. By aligning with these initiatives, we make progress towards research that’s both inclusive and impactful, benefiting local and global communities alike.”
Participating FSLN institutions include:
- Agriculture and Agri-Food Canada
- Environment and Climate Change Canada
- Health Canada
- National Research Council Canada
- Natural Resources Canada
By partnering with some of Canada’s largest science-based agencies, we reaffirm our goal of advancing OA across continents. We look forward to developing our support for Canadian researchers and continuing to drive progress in Open Science across North America and beyond.
Chief Executive Officer
MDPI AG
16 July 2025
Meet Us at the ESMO Congress 2025, 17–21 October 2025, Berlin, Germany

The ESMO Congress is a significant global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2025 aims to converge groundbreaking discoveries, innovative treatments and collaborative approaches to shape the future of cancer care. This event provides the opportunity to learn from internationally renowned experts, engage in thought-provoking discussions and connect with fellow oncology professionals who are advancing diagnosis, treatment and survivorship in this field.
The following MDPI journals will be represented at this conference:
- Cancers;
- Current Oncology;
- Life;
- JCM;
- Hematology Reports;
- CIMB;
- Cells;
- Oral;
- Uro;
- Pharmaceuticals;
- Gastroenterology Insights;
- Diagnostics;
- Targets;
- JPM;
- Onco;
- Radiation;
- Diseases;
- Hemato;
- Livers.
If you are planning to attend the above conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #P2007 and answering any questions that you may have.
For more information about this conference, please visit the following website: https://www.esmo.org/meeting-calendar/esmo-congress-2025.
10 July 2025
Meet Us at the 9th Sino-American Workshop on Biomedical Engineering (SAWBE) and the China–Oversea Joint Workshop on Biomechanics (COWB), 22–26 July 2025, Chengdu, China

MDPI will be attending the 9th Sino-American Workshop on Biomedical Engineering (SAWBE) and China–Oversea Joint Workshop on Biomechanics (COWB), held in Chengdu, China, from 22 to 26 July 2025, at booth# 14.
The 9th Sino-American Workshop on Biomedical Engineering and China–Oversea Joint Workshop on Biomechanics is one of the series of academic exchange activities held every three years. The purpose of the workshop is to further strengthen academic exchanges and cooperation among Chinese scholars at home and abroad, and to promote the development of biomedical engineering and biomechanics in our country. Since its inception in 2001 (first session, Beijing), the workshop has successfully held eight sessions: the second session in 2004 (Shanghai/Chengdu/Beijing), the third session in 2007 (Guangzhou), the fourth session in 2010 (Chongqing), the fifth session in 2013 (Beijing), the sixth session in 2016 (Shanghai), the seventh session in 2019 (Chongqing), and the eighth session in 2022 (Beijing). It has become a series of high-end conferences with brand recognition in the field, significantly promoting international cooperation and talent cultivation, and facilitating the development of biomedical engineering and biomechanics in our country.
The following MDPI journals will be represented:
- Biomechanics;
- Biology;
- Current Oncology;
- Medical Sciences;
- Journal of Developmental Biology;
- Biomolecules;
- Biophysica.
Our representatives, Ms. Callie Liu and Mr. Kent Zhang, are eager to answer your questions and address any inquiries you may have.
If you are attending this conference, please feel free to start a conversation with us at our booth. For more information about the conference, please visit the following website: https://www.sawbe2025.com/site/pages/index/index?pageId=ca390000-f8ac-3e07-a2bb-08dcfd75c495.
8 July 2025
MDPI’s Journal Cluster of Oncology

According to the World Health Organization, cancer is a leading cause of mortality and accounted for approximately 10 million deaths in 2020. Therefore, continued research regarding understanding, diagnosing, and treating cancer is a global priority. The ever-evolving field of oncology spans innovations and discoveries in tumor biology, immunotherapy, targeted treatments, early detection, and personalized medicine.
The mission of MDPI’s cluster of oncology-related journals is to publish high-impact research with potential to redefine cancer treatment and care. Addressing topics from solid tumors to hematologic malignancies, from rare cancers to novel therapeutics, these journals provide a dynamic platform for groundbreaking discoveries and clinical advancements that shape the future of oncology.
The four participating journals are as follows:
- Cancers (ISSN: 2072-6694) focuses on publishing high-quality clinical, translational, and basic science research on cancer prevention, initiation, progression, and treatment, as well as other related topics. In particular, it showcases the most seminal studies in the rapidly growing areas of immunology, immunotherapy, and tumor microenvironment research. Cancers is led by its Editor-in-Chief, Prof. Dr. Samuel C. Mok;
- Current Oncology (ISSN: 1718-7729) is dedicated to advancing cancer care and therapy via publishing clinically relevant research with direct applications to oncology practice. Since its establishment in 1994, the journal has played an important role in disseminating new knowledge across the entire cancer care continuum, spanning the prevention, early detection, and diagnosis of cancer; treatment, including systemic therapy, radiation therapy, and surgery; supportive care; and survivorship care. Additionally, it highlights the critical role of biomarkers and biomarker-driven research in guiding personalized oncology. Affiliated with several key cancer societies, Current Oncology provides a global platform to share scientific progress in oncology. The journal is led by its Editor-in-Chief, Prof. Dr. Shahid Ahmed;
- Onco (ISSN: 2673-7523) functions as a scientific forum integrating novel preclinical, translational, and clinical cancer research and is focused on (but not limited to) the following topics: cancer cell signaling; cancer genetics and molecular targets; cancer epigenetics and heterogeneity; carcinogenesis and cancer evolution; microbiomes and cancer; cancer metabolomics; cancer biomarkers; cancer dormancy; novel targeted and immune cancer therapies; randomized clinical trials; oncotargets; cancer therapies; and clinical reports proposing novel therapeutic regimens. Onco is led by its Editor-in-Chief, Dr. Constantin N. Baxevanis;
- Targets (ISSN: 2813-3137) is centered on, but not limited to, discovering novel molecules which act as diagnostic biomarkers and therapeutic targets, establishing new bionic recognition systems for biosensing and bioimaging, developing novel approaches for biomarker detection, related applications of biological interaction monitoring and targeted therapy, designing new signal amplification strategies for biosensing and cellular or in vivo imaging, utilizing molecular recognition for single-molecule or single-cell analysis, elucidating new pathways or mechanisms in disease development and progression, and synthesizing smart nanomaterials for activatable imaging and responsive drug release. Targets is led by its Editor-in-Chief, Prof. Dr. Huangxian Ju.
|
Launch Year |
Impact Factor (2024) |
CiteScore (2024) |
Time to First Decision (Median) |
APC (CHF) |
2009 |
4.4 |
8.8 |
17.4 days |
2900 |
|
1994 |
3.4 |
4.9 |
19.8 days |
2200 |
|
2021 |
/ |
/ |
27.8 days |
1000 |
|
2023 |
/ |
/ |
28.4 days |
1000 |
MDPI’s mission and values:
As a pioneer in academic open access publishing, MDPI has been serving the scientific community since 1996. Our aim is to foster scientific exchange in all forms and across all disciplines. MDPI's guidelines for disseminating open science are based on the following values and guiding principles:
- Open Access—All our content is published in open access format and distributed under a Creative Commons License, providing free access to the latest research and allowing articles to be freely shared and content to be re-used with proper attribution;
- Timeliness and Efficiency—We rapidly publish novel research through a thorough editorial process, ensuring that a first decision is provided to authors in under 32 days and that papers are published within 7–10 days upon acceptance;
- Simplicity—We offer user-friendly tools and services on our integrated system to enhance the efficiency of our editorial process;
- High-Quality Service—We support scholars and their work by providing a range of options, such as publication in journals at mdpi.com, early publication at preprints.org, and the publication of conferences at sciforum.net, to positively impact research;
- Flexibility—We adapt and develop new tools and services to meet the changing needs of the research community, driven by feedback from authors, editors, and readers;
- Rooted in Sustainability—We ensure the long-term preservation of published papers and support the future of science through partnerships, sponsorships, and awards.
By adhering to these values and principles, MDPI remains committed to advancing scientific knowledge and promoting open-science practices.
Selected Topics:
- “Cancer Biology and Radiation Therapy: 2nd Edition”;
- “Hepatobiliary and Pancreatic Diseases: Novel Strategies of Diagnosis and Treatments”;
- “Biomarkers of Disease: Discovery and Clinical Applications”;
- “Recent Advances in Anticancer Strategies, 2nd Edition”.
Selected Articles:
Cancers
“Generation of Hydrogen Peroxide in Cancer Cells: Advancing Therapeutic Approaches for Cancer Treatment”
Cancers 2024, 16(12), 2171; https://doi.org/10.3390/cancers16122171
Current Oncology
“Relapsed/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse”
Curr. Oncol. 2023, 30(2), 2322-2347; https://doi.org/10.3390/curroncol30020179
Onco
“Significance of PET/CT Imaging in Myeloma Assessment: Exploring Novel Applications beyond Osteolytic Lesion Detection and Treatment Response”
Onco 2024, 4(1), 15-36; https://doi.org/10.3390/onco4010002
Targets
“Potential of MMP-2 and MMP-9 Gelatinase Blockade as a Therapeutic Strategy in Fibrosarcoma Treatment: A Decadal Review”
Targets 2024, 2(2), 104-125; https://doi.org/10.3390/targets2020007